Price T Rowe Associates Inc Clearside Biomedical, Inc. Transaction History

Price T Rowe Associates Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.35 - $2.88 $15,255 - $32,544	11,300 Added 94.96%	23,200 $53,000
Q4 2021 Feb 14, 2022	BUY	$2.72 - $5.72 $32,368 - $68,068	11,900 New	11,900 $33,000
Q3 2021 Nov 15, 2021	SELL	$4.83 - $7.2 $179,676 - $267,840	-37,200 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.32 - $5.38 $28,767 - $66,712	-12,400 Reduced 25.0%	37,200 $181,000
Q1 2021 May 17, 2021	BUY	$2.24 - $4.25 $111,104 - $210,800	49,600 New	49,600 $123,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.